NO302274B1 - Anvendelse av 9-cis retinsyre - Google Patents

Anvendelse av 9-cis retinsyre

Info

Publication number
NO302274B1
NO302274B1 NO930206A NO930206A NO302274B1 NO 302274 B1 NO302274 B1 NO 302274B1 NO 930206 A NO930206 A NO 930206A NO 930206 A NO930206 A NO 930206A NO 302274 B1 NO302274 B1 NO 302274B1
Authority
NO
Norway
Prior art keywords
retinoic acid
cis retinoic
psoriasis
malignant
esters
Prior art date
Application number
NO930206A
Other languages
English (en)
Norwegian (no)
Other versions
NO930206D0 (no
NO930206L (no
Inventor
Werner Bollag
Joseph Francis Grippo
Arthur Levin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO930206D0 publication Critical patent/NO930206D0/no
Publication of NO930206L publication Critical patent/NO930206L/no
Publication of NO302274B1 publication Critical patent/NO302274B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
NO930206A 1992-01-22 1993-01-21 Anvendelse av 9-cis retinsyre NO302274B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82378692A 1992-01-22 1992-01-22
US82374192A 1992-01-22 1992-01-22
US82392892A 1992-01-22 1992-01-22
US82464792A 1992-01-23 1992-01-23

Publications (3)

Publication Number Publication Date
NO930206D0 NO930206D0 (no) 1993-01-21
NO930206L NO930206L (no) 1993-07-23
NO302274B1 true NO302274B1 (no) 1998-02-16

Family

ID=27505866

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930206A NO302274B1 (no) 1992-01-22 1993-01-21 Anvendelse av 9-cis retinsyre

Country Status (20)

Country Link
EP (1) EP0552624B1 (cs)
JP (1) JP3631259B2 (cs)
CN (2) CN1068200C (cs)
AT (1) ATE194077T1 (cs)
AU (1) AU667864B2 (cs)
CA (1) CA2087251C (cs)
CY (1) CY2251B1 (cs)
CZ (1) CZ282548B6 (cs)
DE (1) DE69328910T2 (cs)
DK (1) DK0552624T3 (cs)
ES (1) ES2148184T3 (cs)
GR (1) GR3034323T3 (cs)
HU (2) HU212734B (cs)
IL (1) IL104450A (cs)
NO (1) NO302274B1 (cs)
NZ (1) NZ245686A (cs)
PH (1) PH31621A (cs)
PT (1) PT552624E (cs)
RU (1) RU2119333C1 (cs)
TW (1) TW226329B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69224660C5 (de) 1991-12-18 2010-06-02 The Salk Institute For Biological Studies, La Jolla Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen
US5968989A (en) 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US7056954B2 (en) 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US5962731A (en) * 1992-04-22 1999-10-05 Ligand Pharmaceuticals Incorporated Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5549888A (en) * 1994-01-31 1996-08-27 Procter & Gamble Aqueous topical anti-acne compositions of low pH
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
US5821254A (en) * 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
US5807900A (en) * 1995-03-31 1998-09-15 Hoffmann-La Roche, Inc. Method for identifying compounds having increased activity for the repair of skin photodamage
EP0822811A1 (en) * 1995-04-21 1998-02-11 Ligand Pharmaceuticals, Inc. Inhibition of apoptosis in cells expressing fas-ligand following activation
DE19523079A1 (de) * 1995-06-26 1997-01-02 Basf Ag Ester und Amide der 9(Z)-Retinsäure
AU725998B2 (en) * 1995-09-18 2000-10-26 Eisai R&D Management Co., Ltd. Treating NIDDM with RXR agonists
WO1997010813A1 (en) * 1995-09-18 1997-03-27 Ligand Pharmaceuticals Incorporated Ppar gamma antagonists for treating obesity
TW442459B (en) * 1996-04-15 2001-06-23 Hoffmann La Roche Retinoid compounds, pharmaceutical composition comprising same and process for the preparation thereof
FR2765480B1 (fr) 1997-07-07 1999-09-10 Oreal Utilisation pour le revetement des matieres keratiniques d'un materiau polymerique hybride ; compositions cosmetiques ou dermatologiques
WO1999005161A1 (en) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
WO1999048529A1 (en) * 1998-03-20 1999-09-30 Warner-Lambert Company Retinoid-glitazone combinations
CN1162427C (zh) 1999-04-07 2004-08-18 三共株式会社 用作药物的胺衍生物化合物及其可药用盐或酯
AU3082901A (en) * 1999-11-23 2001-06-04 Gerhart Graupner Modulation of signal transduction
RU2214830C2 (ru) * 2001-12-03 2003-10-27 Рязанский государственный медицинский университет им. акад. И.П.Павлова Способ лечения и профилактики местных лучевых реакций на коже
JP5249484B2 (ja) * 2001-12-11 2013-07-31 第一三共株式会社 医薬組成物
EP1496879A4 (en) * 2002-04-05 2008-06-18 Univ Utah Res Found Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
RU2197235C1 (ru) * 2002-04-05 2003-01-27 Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа) Раствор для лечения заболеваний кожи, способ его получения и способ лечения заболеваний кожи
US20040122110A1 (en) * 2002-09-06 2004-06-24 Maccabee Mendy S. Effect of vitamin A gel on paranasal sinus mucosal regeneration
EP1527774A1 (en) 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
JP4825957B2 (ja) * 2005-03-29 2011-11-30 国立大学法人 鹿児島大学 抗腫瘍剤
CN102612375B (zh) 2009-09-15 2016-01-27 Qlt股份有限公司 含有在脂质媒介物中的9-顺式-视黄酯的药物制剂
EP2558102A4 (en) * 2010-04-16 2013-09-25 Davos Life Science Pte Ltd SYNERGISTIC INTERACTION OF AT LEAST ONE COMPONENT OF VITAMIN E AND TYROSINASE INHIBITORS FOR DERMATOLOGICAL APPLICATIONS
EP2563350B1 (en) 2010-04-19 2020-10-14 Retinagenix Therapeutics, Inc. Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency
BR112014021602A2 (pt) 2012-03-01 2021-06-08 Quadra Logic Tech Inc uso, kit e derivado de retinal sintético para melhorar a função visual em distúrbios visuais associados com a deficiência de produção endógena de retinóide
JP6182728B2 (ja) * 2012-11-02 2017-08-23 国立大学法人名古屋大学 幹細胞を標的とした薬効及び毒性の評価法
EP4215178A1 (en) 2020-09-11 2023-07-26 Chemyunion Ltda Composition, use of the composition, cosmetic method and method for modulating the production of sebum
JP2025508115A (ja) * 2022-03-08 2025-03-21 マスタリー バイオテック カンパニー，リミテッド レチノイン酸および炭水化物を含む医薬組成物ならびにその使用
WO2025077810A1 (zh) * 2023-10-12 2025-04-17 南京纽邦生物科技有限公司 预防或延缓皮肤衰老及维持或改善皮肤状况的方法和组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
DE3853427T2 (de) * 1987-04-06 1995-12-14 Daltex Medical Sciences Inc Behandlung gealterter haut mit oraler 13-cis-retinsäure.
US4994491A (en) * 1988-12-14 1991-02-19 Molecular Design International Dermal uses of trans-retinoids for the treatment of cancer
LU86969A1 (fr) * 1987-08-12 1989-03-08 Oreal Association de derives de pyrimidine et de retinoides en composants separes pour induire et stimuler la croissance des cheveux et diminuer leur chute
DE69224660C5 (de) * 1991-12-18 2010-06-02 The Salk Institute For Biological Studies, La Jolla Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen

Also Published As

Publication number Publication date
HUT63053A (en) 1993-07-28
JPH06107542A (ja) 1994-04-19
CY2251B1 (en) 2003-07-04
TW226329B (cs) 1994-07-11
IL104450A (en) 1997-03-18
EP0552624B1 (en) 2000-06-28
ES2148184T3 (es) 2000-10-16
HU9300116D0 (en) 1993-04-28
AU3186193A (en) 1993-07-29
CN1068200C (zh) 2001-07-11
CN1074826A (zh) 1993-08-04
HU211167A9 (en) 1995-11-28
DE69328910D1 (de) 2000-08-03
ATE194077T1 (de) 2000-07-15
CZ372892A3 (en) 1993-12-15
CA2087251C (en) 2003-06-24
DE69328910T2 (de) 2001-01-11
GR3034323T3 (en) 2000-12-29
CN1256916A (zh) 2000-06-21
CA2087251A1 (en) 1993-07-23
CZ282548B6 (cs) 1997-08-13
NO930206D0 (no) 1993-01-21
PT552624E (pt) 2000-10-31
DK0552624T3 (da) 2000-09-25
NZ245686A (en) 1995-05-26
PH31621A (en) 1999-01-12
RU2119333C1 (ru) 1998-09-27
JP3631259B2 (ja) 2005-03-23
CN1155376C (zh) 2004-06-30
AU667864B2 (en) 1996-04-18
HU212734B (en) 1996-10-28
EP0552624A1 (en) 1993-07-28
NO930206L (no) 1993-07-23
IL104450A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
NO302274B1 (no) Anvendelse av 9-cis retinsyre
RU93005355A (ru) Фармакологические композиции
AU2080988A (en) Esters of 13-trans-retinoic acid
KR950700722A (ko) 피부 보호 방법 및 그 조성물(Skin Care Method and Composition)
EP0213765A3 (en) A method and device for performing transluminal angioplasty
EP0303915A3 (en) Retinoids for the treatment of skin damaged by light
DE69029100D1 (de) Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
KR930016100A (ko) 약제학적 조성물
ATE70183T1 (de) Topische zubereitungen mit gehalt an teer und fettsaeuren.
ATE147265T1 (de) Verwendung von retinoiden zur umkehr glucocorticoid-induzierter hautatrophie
ES2054687T3 (es) Utilizacion de medetomidina en la fabricacion de un medicamento.
DE68919009D1 (de) Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten.
TR199700694T1 (xx) D vitamini t�revlerinin dermotolojik kullan�m�.
ATE171703T1 (de) Hydroxyamin-n-acyl-derivate mit radikalfängeraktivität und nützlich in akuten und chronischen erkrankungen die mit peroxidations- und entzündungserscheinungen einhergehen
IE873478L (en) Use of 13-cis retinoic acid
AU6608994A (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
ES2064958T3 (es) Gel acuoso a base de acido retinoico y de hidroxipropil-beta-ciclodextrina.
NO920805D0 (no) Metoder for forhindring og redusering av stoerrelsen av striae distensae-lesjoner
IT1242478B (it) Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto.
ATE97812T1 (de) Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen.
ATE99929T1 (de) Behandlung von periodontoklasie mit retinsaeure.
DE58905981D1 (de) Verwendung von hexatrienderivaten zur herstellung von mitteln gegen akne, psoriasis und lichtschäden der haut.
ITTN930007A1 (it) Associazione di lattato d' ammonio ( 15% ) e acido azelaico ( 20% ) prodotto cosmetico indicato nelle pelli acneiche e/o iperseborroiche
ITBL930018A0 (it) Metodo per la produzione di unguento per malattie della pelle ed un- guento cosi' ottenuto

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees